期刊文献+

细胞因子信号抑制因子在Vogt-小柳原田病患者外周血单个核细胞的表达 被引量:2

Expression of suppressor of cytokine signaling in peripheral blood monocular cells of patients with Vogt-Koyanagi-Harada disease
原文传递
导出
摘要 目的探讨Vogt-小柳原田病(Vogt-Koyanagi-Harada,VKH)患者外周血单个核细胞(peripheral blood mononuclear cell,PBMC)细胞因子信号抑制因子(suppressor of cytokine signaling,SOCS)的表达。方法本研究设计为病例对照研究。抽取15例VKH活动期患者、17例静止期患者和16例正常人的外周血,用酶联免疫吸附测定方法检测血清中细胞因子IL-4、IL-12、IFN-γ的水平;用实时荧光定量PCR和蛋白免疫印迹方法检测外周血单个核细胞内SOCS基因和蛋白的表达,对三组实验结果数据采用方差分析中的两两比较进行统计。结果活动期和静止期VKH患者及正常对照组血清中IL-4水平分别为(28.40±5.93)、(34.5±9.47)和(11.25±4.43)ng/L,IL-12的水平为(24.33±8.55)、(11.53±6.11)和(5.19±2.43)ng/L,IFN-γ的水平为(18.05±2.23)、(15.53±2.63)和(1.61±3.47)ng/L,IL-4、IL-12和IFN-γ在活动期和静止期VKH患者血清中的水平均较正常对照组显著升高(P〈0.01)。IL4在静止期患者较活动期患者水平升高(P〈0.01)。IL-12和IFN-γ在静止期患者较活动期患者水平低(P〈0.01,P〈0.05)。SOSC基因表达的检测结果显示含SH2结构的细胞因子诱导蛋白(cytokine inducible SH2 containing protein,CIS)、SOCS1、SOCS2、SOCS3、SOCS5mRNA在VKH活动期患者PBMC内的表达分别是正常对照组的0.72、4.92、1.09、0.75和1.15倍,静止期患者是正常对照组的1.15、2.25、1.40、0.69和1.16倍。蛋白免疫印迹结果显示活动期患者的CIS水平显著低于静止期患者和正常人(P〈0.01),静止期和正常对照组之间差异无统计学意义(P〉0.05);SOCS1在活动期患者体内显著高于静止期患者和正常对照组(P〈0.01,P〈0.05),静止期和正常对照组之间差异无统计学意义(P〉0.05);SOCS2在患者和正常人之间无明显差别(均P〉0.05);活动期和静止期患者的SOCS3均明显较正常对照组降低(P〈0.05);SOCS5在两组患者体内的水平均高于正常对照组(P〈0.01),且静止期患者的水平显著高于活动期(P〈0.05)。结论VKH患者PBMC内SOCS1和SOCS5水平升高、CIS和SOCS3水平降低与VKH发生过程中的Th1型反应增强有关。SOCS5在葡萄膜炎发生过程中可能起保护作用。临床上静止期的葡萄膜炎患者体内的免疫环境仍处于异常状态,这可能是葡萄膜炎易复发和慢性化的原因。 Objective To investigate suppressor of cytokine signaling (SOCS) mRNA and protein expression in peripheral blood mononuclear cells (PBMC) of patients with Vogt-Koyanagi-Harada (VKH) disease. Methods Blood samples were taken from 15 VKH patients with active uveitis, 17 quiescent patients and 16 healthy individuals. IFN-7, IL-12 and IL-4 in the serum were measured by ELISA. PBMC were subjected to analysis of SOCS mRNA and protein expression using quantitative RT-PCR and western blot, respectively. Results The level of IL-γ in the serum of VKH patients and in controls were (28.40 ± 5.93 ) ng/L, (34. 5 ±9.47) ng/L and ( 11.25± 4.43) ng/L, IL-12 were (24. 33 ±8.55 ) ng/L, ( 11.53 ±6.11)ng/L and (5.19 ± 2. 43 ) ng/L, IFN-γ were (18.05±2.23)ng/L, (15.53±2.63)ng/L and (1.61± 3.47)ng/L, respectively. The level of IFN-γ, IL-12 and IL-4 were all significantly higher in the serum of VKH patients than in controls ( P 〈 0.01 ). IL-4 in quiescent patients was higher than in active patients (P 〈0. 01 ), IL-12 and IFN-γ were lower in quiescent patients was higher than in active patients (P 〈 0. 01, P 〈 0. 05). Cytokine inducible SH2 containing protein (CIS) mRNA, SOCS1 mRNA, SOCS2 mRNA, SOCS3 mRNA and SOCS5 mRNA levels in PBMC of VKH patients with active uveitis are 0. 72, 4.92, 1.09, 0.75 and 1.15 folds than that in healthy volunteers, respectively. They are 1.15, 2.25, 1.40, 0. 69 and 1.16 folds in static patients, respectively. Marked decreased expression of CIS protein is detected in both active and quiescent patients with no significant difference between two groups ( both P 〈 0. O1 ). SOCS1 protein is up-regulated significantly in active patients compares to in quiescent patients nor in healthy volunteers (P 〈 0. 01, P 〈 0. 05 ). SOCS3 protein is significantly decreased in patients than in controls(both P 〈0. 05). SOCS5 protein is much higher in patients than in controls(both P 〈0.01 ), and even higher in quiescent patients than in active episode ( P 〈 0. 05 ). Conclusions Up regulation of SOCS1 and SOCS5 expression and down-regulation of SOCS3 and CIS may correlate with the development of a Thl mediated immune response in VKH disease. There is insidious inflammation in VKH patients with clinically quiescent uveitis, and this may be one of the causes of persistence and recurrences of uveitis.
出处 《中华眼科杂志》 CAS CSCD 北大核心 2009年第11期1015-1019,共5页 Chinese Journal of Ophthalmology
基金 基金项目:国家自然科学基金(30400490) 北京市自然科学基金(7052023)
关键词 细胞因子信号传导蛋白抑制因子 葡萄膜脑膜脑炎综合征 白细胞 单核 细胞因子类 Suppressor of cytokine signaling proteins Uveomeningoencephalitic syndrome Leukocytes, mononuclear Cytokines
  • 相关文献

参考文献19

  • 1杨培增,王红,周红颜,钟华红,李芬芳,黄祥坤,钟晖,傅涛.Vogt-Koyanagi-Harada综合征的治疗[J].中华眼科杂志,2002,38(4):196-199. 被引量:38
  • 2Kiyoko G, Isao K, Kunihiko Y. Identification of autoreactive T cells in Vogt-Koyanagi-Harada disease. Invest Ophthalmol Vis Sci, 2001, 42: 2004-2009.
  • 3Rao NA. Mechanisms of inflammation response in sympathetic ophthalmia and Vogt-Koyanagi-Harada syndrome. Eye, 1997, 11 : 213-2!6.
  • 4Norose K, Yano A, Wang XC, et al. Dominance of activated T cells and IL-6 in aqueous humor in Vogt-Koyanagi-Harada disease. Invest Ophthalmol Vis Sci, 1994, 35 : 33-39.
  • 5Gocho K, Kondo I, Yamaki K. Identification of autoreactive T ceils in Vogt-Koyanagi-Harada disease. Invest Ophthalmol Vis Sci, 2001, 42: 2004-2009.
  • 6Imai Y, Sugita S, Nakamura K, et al. Cytokine production and helper T cell subsets in Vogt-Koyanagi-Harada disease. Curr Eye Res, 2001, 22: 312-318.
  • 7Egwuagu CE, Yu CR, Li ZQ, et al. SOCS5 mRNA levels in peripheral blood mononuclear cells (PBMC): a potential biomarker for monitoring response of uveitis patients to Daclizumab therapy. J Autoimmun, 2005, 24:39-46.
  • 8Miyazawa I, Abe T, Narikawa K, et al. Chemokine profile in the cerebrospinal fluid and serum of Vogt-Koyanagi-Harada disease. J Neuroimmunol, 2005, 158 : 240-244.
  • 9Seki Y, Inoue H, Nagata N, et al. SOCS-3 regulates onset and maintenance of Th2-mediated allergic responses. Nat Med, 2003, 9 : 1047-1054.
  • 10Egan PJ, Lawlor KE, Alexander WS, et al. Suppressor of cytokine signaling-1 regulates acute inflammatory arthritis and T cell activation. J Clin Invest,2003, 111 : 915-924.

二级参考文献12

  • 1Caspi RR. Thl and Th2 responses in pathogenesis and regulation of experimental autoimmune uveoretinitis. Int Rev Immunol, 2002,21:197-208.
  • 2Egwuagu CE, Yu CR, Zhang M, et ah Suppressors of cytokine signaling proteins are differentially expressed in Th1 and Th2 cells: implications for Th cell lineage commitment and maintenance. J Immunol, 2002,168:3181-3187.
  • 3Yamamoto K, Yamaguchi M, Miyasaka N, et al. SOCS-3 inhibits IL-12-induced STAT4 activation by binding through its SH2 domain to the STAT4 docking site in the IL-12 receptor beta2 subunit. Biochem Biophys Res Commun, 2003 310 : 1188- 1193.
  • 4Gery L, Mochizuki M, Nussenblatt RB, et al. Retinal specific antigens and immunopathogenic processes they provoke// Osborne N, Chader J. Progress in retina research. New York: Pergamon Press, 1986 : 75 -109.
  • 5de Smet MD, Bitar G, Roberge FG, et al. Human S2 antigenz presence of multiple immunogenie and immunopathogenic sites in Lewis rat. J Autoimmun, 1993, 6:587- 599.
  • 6Livak K J, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2( Delta Delta C (T)) Method. Methods,2001,25:402 -408.
  • 7Wurster AL, Tanaka T, Grusby MJ. The biology of Stat4 and Stat6. Oncogene, 2000,19:2577-2584.
  • 8Seki Y, Inoue H, Nagata N, et al. SOCS 3 regulates onset and maintenance of T (H) 2-mediated allergic responses. Nat Med, 2003, 9:1047-1054.
  • 9Seki Y, Hayashi K, Matsumoto A, et al. Expression of SOCS5 negatively regulates IL-4 dependent STAT activation and Th2 differentiation. Proe Natl Acad Sei USA, 2002, 99: 13003- 13008.
  • 10冯亦颖,刘炳治,王巨存.龙胆泻肝汤对氧自由基和由羟自由基诱导的脂质过氧化的影响[J].中国中医眼科杂志,2000,10(2):63-65. 被引量:19

共引文献38

同被引文献10

  • 1Yang P,Zhang Z,Zhou H, et al. Clinical patterns and characteris- tics of uveitis in a tertiary center for uveitis in China. Curt Eye Res, 2005,30:943 -948.
  • 2Su DH, Chee SP. Sympathetic ophthalmia in Singapore: new trend in an old disease. Graefes Arch Clin Exp Ophthalmol,2006, 244:243 - 247.
  • 3Egwuagu CE, Yu CR, Zhang M, et al. Suppressors of cytokine signaling proteins are differentially expressed in Thl and Th2 cells: implications for Th cell lineage commitment and mainte- nance. J Immunol, 2002,168:3181 - 3187.
  • 4Wormald S, Zhang JG, Krebs DL, et al. The comparative roles of suppressor of cytokine signaling-1 and -3 in the inhibition and de- sensitization of cytokine signaling. J Biol Chem, 2006,281 : 11135 - 11143.
  • 5Takatori H, Nakajima H, Kagami S, et al. Stat 5a inhibits IL-12- induced Thl cell differentiation through the induction of suppressor of cytokine signaling 3 expression. J Immunol, 2005,174:4105 - 4112.
  • 6Whyte CS, Bishop ET, Rtlekerl D, et al. Suppressor of cytokine signaling (SOCS)1 is a key determinant of differential macrophage activation and function. J Leukoc Biol,2011,90 : 845 - 854.
  • 7Seki Y, Inoue H, Nagata N, et al. SOCS-3 regulates onset and maintenance of T ( H ) 2-mediated allergic responses. Nat Med, 2003, 9:1047 - 1054.
  • 8Liu Y, Stewart KN, Bishop E, et al. Unique expression of sup- pressor of eytokine signaling 3 is essential for classical maerophage aetlvation in rodents in vitro and in vivo. J Immunol, 2008, 180: 6270 - 6278.
  • 9Takase H, Yu CR, Liu X, et al. Induction of suppressors of cyto- kine signaling (SOCS) in the retina during experimental autoim- mune uveitis (EAU) :Potential neuropretective role of SOCS pro- teins. J Neuroimmunol, 2005, 168 : 118 - 127.
  • 10Seki Y, Hayashi K, Matsumoto A, et al. Expression of SOCS5 negatively regulates IL-4 dependent STAT activation and Th2 dif- ferentiation. Proc Natl Acad Sci USA, 2002, 99:13003 - 13008.

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部